{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:54:40Z","timestamp":1740174880490,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40792-018-0528-y","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T09:11:39Z","timestamp":1537175499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9906-7621","authenticated-orcid":false,"given":"Ritsuko","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Edahiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsue","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"issue":"7","key":"528_CR1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1538-7836.2007.02572.x","volume":"5","author":"PJ Lenting","year":"2007","unstructured":"Lenting PJ, CJ VANS, Denis CV. Clearance mechanisms of von Willebrand factor and factor VIII. J Thromb Haemost. 2007;5(7):1353\u201360.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"528_CR2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","volume":"69","author":"F Rodeghiero","year":"1987","unstructured":"Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand\u2019s disease. Blood. 1987;69(2):454\u20139.","journal-title":"Blood"},{"issue":"25","key":"528_CR3","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","volume":"117","author":"A Tiede","year":"2011","unstructured":"Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011;117(25):6777\u201385.","journal-title":"Blood"},{"issue":"2","key":"528_CR4","first-page":"345","volume":"84","author":"AB Federici","year":"2000","unstructured":"Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, et al. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000;84(2):345\u20139.","journal-title":"Thromb Haemost"},{"issue":"6","key":"528_CR5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","volume":"31","author":"JV Simone","year":"1968","unstructured":"Simone JV, Cornet JA, Abildgaard CF. Acquired von Willebrand\u2019s syndrome in systemic lupus erythematosus. Blood. 1968;31(6):806\u201312.","journal-title":"Blood"},{"issue":"6","key":"528_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0002-9343(97)00239-8","volume":"103","author":"A Tefferi","year":"1997","unstructured":"Tefferi A, Nichols WL. Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment. Am J Med. 1997;103(6):536\u201340.","journal-title":"Am J Med"},{"issue":"5","key":"528_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1046\/j.1365-2516.1999.00340.x","volume":"5","author":"IC Nitu-Whalley","year":"1999","unstructured":"Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome--report of 10 cases and review of the literature. Haemophilia. 1999;5(5):318\u201326.","journal-title":"Haemophilia"},{"key":"528_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2016.12.027","volume":"151","author":"A Sedaghat","year":"2017","unstructured":"Sedaghat A, Kulka H, Sinning JM, Falkenberg N, Driesen J, Preisler B, et al. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI. Thromb Res. 2017;151:23\u20138.","journal-title":"Thromb Res"},{"issue":"4","key":"528_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jocs.12131","volume":"28","author":"RA Saad","year":"2013","unstructured":"Saad RA, Lwaleed BA, Kazmi RS. Gastrointestinal bleeding and aortic stenosis (Heyde syndrome): the role of aortic valve replacement. J Card Surg. 2013;28(4):414\u20136.","journal-title":"J Card Surg"},{"issue":"2","key":"528_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/ejh.12809","volume":"98","author":"W Miesbach","year":"2017","unstructured":"Miesbach W, Berntorp E. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery. Eur J Haematol. 2017;98(2):121\u20137.","journal-title":"Eur J Haematol"},{"issue":"2","key":"528_CR11","first-page":"s33","volume":"6","author":"M Franchini","year":"2008","unstructured":"Franchini M. Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage. Blood Transfus. 2008;6(2):s33\u20138.","journal-title":"Blood Transfus"},{"key":"528_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/JBM.S152663","volume":"9","author":"CM Baldeo","year":"2018","unstructured":"Baldeo CM, Rivera CE, Tun HW, Vishnu P. Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report. J Blood Med. 2018;9:9\u201313.","journal-title":"J Blood Med"},{"issue":"7","key":"528_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/j.1538-7836.2007.02588.x","volume":"5","author":"S Lethagen","year":"2007","unstructured":"Lethagen S, Kyrle PA, Castaman G, Haertel S, Mannucci PM. von Willebrand factor\/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery. J Thromb Haemost. 2007;5(7):1420\u201330.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"528_CR14","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/01.mbc.0000167658.85143.49","volume":"16","author":"AB Federici","year":"2005","unstructured":"Federici AB. Management of von Willebrand disease with factor VIII\/von Willebrand factor concentrates: results from current studies and surveys. Blood Coagul Fibrinolysis. 2005;16(1):S17\u201321.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"528_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.thromres.2015.07.029","volume":"136","author":"A Mital","year":"2015","unstructured":"Mital A, Prejzner W, Swiatkowska-Stodulska R, Hellmann A. Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera - retrospective analysis of 142 consecutive cases. Thromb Res. 2015;136(4):754\u20137.","journal-title":"Thromb Res"},{"issue":"3","key":"528_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0268-960X(91)90032-8","volume":"5","author":"F Rodeghiero","year":"1991","unstructured":"Rodeghiero F, Castaman G, Mannucci PM. Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev. 1991;5(3):155\u201361.","journal-title":"Blood Rev"},{"issue":"977","key":"528_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/pgmj.2006.052118","volume":"83","author":"B Ozgonenel","year":"2007","unstructured":"Ozgonenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin? Postgrad Med J. 2007;83(977):159\u201363.","journal-title":"Postgrad Med J"},{"issue":"6","key":"528_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","volume":"157","author":"PV Jenkins","year":"2012","unstructured":"Jenkins PV, Rawley O, Smith OP, O\u2019Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157(6):653\u201363.","journal-title":"Br J Haematol"},{"issue":"1","key":"528_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0037-1613747","volume":"83","author":"RA Kraaijenhagen","year":"2000","unstructured":"Kraaijenhagen RA, in\u2019t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83(1):5\u20139.","journal-title":"Thromb Haemost"},{"issue":"3","key":"528_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.thromres.2014.12.017","volume":"135","author":"W Miesbach","year":"2015","unstructured":"Miesbach W, Krekeler S, Wolf Z, Seifried E. Clinical use of Haemate(R) P in von Willebrand disease: a 25-year retrospective observational study. Thromb Res. 2015;135(3):479\u201384.","journal-title":"Thromb Res"},{"issue":"8943","key":"528_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet (London, England). 1995;345(8943):152\u20135.","journal-title":"Lancet (London, England)"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-018-0528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T04:55:33Z","timestamp":1571892933000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-018-0528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1186\/s40792-018-0528-y","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"11 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests in this case (TO has received research funding outside of this case).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"118"}}